Efficacy and safety analysis of induction therapy for unresectable locally advanced non-small-cell lung cancer: a retrospective study based on IPTW
Induction chemoimmunotherapy administered prior to definitive CRT confers significant and durable improvements in PFS and OS, with a manageable safety profile.